Vitamin D substrate-product relationship in idiopathic hypercalciuria

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 1-2, 2009, Pages 3-8

  Bevilacqua, Maurizio ^a   Dominguez, Ligia J ^b   Gandolini, Giorgio ^c   Valdes, Valeria ^a   Vago, Tarcisio ^a   Righini, Velella ^a   Barrella, Massimo ^a   Barbagallo, Mario ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Hypercalciuria; Kidney stones; Metabolism; Nutrition; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; OXYGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IDIOPATHIC HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERCALCIURIA; MALE; MIDDLE AGED; SEASONS; VITAMIN D;

EID: 59849097564     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.08.010     Document Type: Article

References (41)

1. Breslau N.A. Normal and abnormal regulation of 1,25-(OH)2D synthesis. Am. J. Med. Sci. 296 (1988) 417-425
2. Vieth R., McCarten K., and Norwich K.H. Role of 25-hydroxyvitamin D3 dose in determining rat 1,25-dihydroxyvitamin D3 production. Am. J. Physiol. 258 (1990) E780-E789
3. Bell N.H., Epstein S., Shary J., Greene V., Oexmann M.J., and Shaw S. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism. J. Bone. Miner. Res. 3 (1988) 489-495
4. LoCascio V., Adami S., Galvanini G., Ferrari M., Cominacini L., and Tartarotti D. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism. N. Engl. J. Med. 313 (1985) 1123-1125
5. Stern P.H., Taylor A.B., Bell N.H., and Epstein S. Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J. Clin. Invest. 68 (1981) 1374-1377
6. Need A.G., Horowitz M., Morris H.A., and Nordin C.B.E. Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women. Am. J. Clin. Nutr. 71 (2000) 1577-1581
7. Lawoyin S., Zerwekh J.E., Glass K., and Pak C.Y. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 50 (1980) 593-596
8. Francis R.M., Peacock M., Storer J.H., Davies A.E., Brown W.B., and Nordin B.E. Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur. J. Clin. Invest. 13 (1983) 391-396
9. Mawer E.B., Berry J.L., Sommer-Tsilenis E., Beykirch W., Kuhlwein A., and Rohde B.T. Ultraviolet irradiation increases serum 1,25-dihydroxyvitamin D in vitamin-D-replete adults. Miner. Electrolyte. Metab. 10 (1984) 117-121
10. Papapoulos S.E., Clemens T.L., Fraher L.J., Gleed J., and O'Riordan J.L. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol. Lancet 2 (1980) 612-615
11. Sandler L.M., Winearls C.G., Fraher L.J., Clemens T.L., Smith R., and O'Riordan J.L. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q. J. Med. 53 (1984) 165-180
12. Halloran B.P., Schaefer P., Lifschitz M., Levens M., and Goldsmith R.S. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J. Clin. Endocrinol. Metab. 59 (1984) 1063-1069
13. Epstein S., Stern P.H., Bell N.H., Dowdeswell I., and Turner R.T. Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif. Tissue. Int. 36 (1984) 541-544
14. Clements M.R., Davies M., Hayes M.E., Hickey C.D., Lumb G.A., Mawer E.B., and Adams P.H. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin. Endocrinol. 37 (1992) 17-27
15. Halloran B.P., Bikle D.D., Levens M.J., Castro M.E., Globus R.K., and Holton E. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. J. Clin. Invest. 78 (1986) 622-628
16. Reinholz G.G., and DeLuca H.F. Inhibition of 25-hydroxyvitamin D3 production by 1, 25-dihydroxyvitamin D3 in rats. Arch. Biochem. Biophys. 355 (1998) 77-83
17. Kaplan R.A., Haussler M.R., Deftos L.J., Bone H., and Pak C.Y. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J. Clin. Invest. 59 (1977) 756-760
18. Broadus A.E., Horst R.L., Lang R., Littledike E.T., and Rasmussen H. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N. Engl. J. Med. 302 (1980) 421-426
19. Broadus A.E., Insogna K.L., Lang R., Ellison A.F., and Dreyer B.E. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N. Engl. J. Med. 311 (1984) 73-80
20. Insogna K.L., Broadus A.E., Dreyer B.E., Ellison A.F., and Gertner J.M. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 61 (1985) 490-495
21. Breslau N.A., Preminger G.M., Adams B.V., Otey J., and Pak C.Y. Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J. Clin. Endocrinol. Metab. 75 (1992) 1446-1452
22. Favus M.J., Karnauskas A.J., Parks J.H., and Coe F.L. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J. Clin. Endocrinol. Metab. 89 (2004) 4937-4943
23. Costa E.M., and Feldman D. Homologous up-regulation of the 1,25(OH)2 vitamin D3 receptor in rats. Biochem. Biophys. Res. Comm. 137 (1986) 742-747
24. Karnauskas A.J., van Leeuwen J.P., van den Bemd G.J., Kathpalia P.P., DeLuca H.F., Bushinsky D.A., and Favus M.J. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J. Bone. Miner. Res. 20 (2005) 447-454
25. Bettica P., Bevilacqua M., Vago T., and Norbiato G. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos. Int. 9 (1999) 226-229
26. Bevilacqua M., Dominguez L.J., Righini V., Valdes V., Toscano R., Sangaletti O., Vago T., Baldi G., Barrella M., and Bianchi-Porro G. Increased gastrin and calcitonin secretion after oral calcium or peptones administration in patients with hypercalciuria: a clue to an alteration in calcium-sensing receptor activity. J. Clin. Endocrinol. Metab. 90 (2005) 1489-1494
27. Pacifici R. Idiopathic hypercalciuria and osteoporosis-distinct clinical manifestations of increased cytokine-induced bone resorption?. J. Clin. Endocrinol. Metab. 82 (1997) 29-31
28. Altman D.G., and Gardner M.J. Calculating confidence intervals for regression and correlation. Brit. Med. J. 206 (1988) 1238-1242
29. Holvik K., Meyer H.E., Sogaard A.J., Haug E., and Falch J.A. Pakistanis living in Oslo have lower serum 1,25-dihydroxyvitamin D levels but higher serum ionized calcium levels compared with ethnic Norwegians. The Oslo health study. B. M. C. Endocr. Disord. 18 (2007) 7-9
30. Barger-Lux M.J., Heaney R.P., Dowell S., Chen T.C., and Holick M.F. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteop. Internat. 8 (1998) 222-230
31. Yao J.J., Bai S., Karnauskas A.J., Bushinsky D.A., and Favus M.J. Regulation of renal calcium receptor gene expression by 1,25-dihydroxyvitamin D3 in genetic hypercalciuric stone-forming rats. J. Am. Soc. Nephrol. 16 (2005) 1300-1308
32. Gluszek J., Raszeja-Wanic B., Grajek S., Kwias Z., Ratajczak T., and Smarsz C. Seasonal variations in urinary excretion of calcium and magnesium in healthy subjects and patients with renal calculus and chronic renal failure. Int. Urol. Nephrol. 10 (1978) 147-152
33. Parks J.H., Barsky R., and Coe F.L. Gender differences in seasonal variation of urine stone risk factors. J. Urol. 170 (2003) 384-388
34. Baker P.W., Coyle P., Bais R., and Rofe A.M. Influence of season, age, and sex on renal stone formation in South Australia. Med. J. Aust. 159 (1993) 390-392
35. Hilgenfeld M.S., Simon S., Blowey D., Richmond W., and Alon U.S. Lack of seasonal variations in urinary calcium/creatinine ration in school-age children. Pediatr. Nephrol. 19 (2004) 1153-1155
36. Hewison M., Zehnder D., Bland R., and Stewart P.M. 1alpha-hydroxylase and the action of vitamin D. J. Mol. Endocrinol. 25 (2000) 141-148
37. St-Arnaud R., Messerlian S., Moir J.M., Omdahl J.L., and Glorieux F.H. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J. Bone. Miner. Res. 12 (1997) 1552-1559
38. Takeyama K., Kitanaka S., Sato T., Kobori M., Yanagisawa J., and Kato S. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277 (1997) 1827-1830
39. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., and Portale A.A. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 11 (1997) 1961-1970
40. Zhang M.Y.H., Wang X., Wang J.T., Compagnone N.A., Mellon S.H., Olson J.L., Tenenhouse H.S., Miller W.L., and Portale A.A. Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1α-hydroxylase gene expression in the proximal renal tubule. Endocrinology 143 (2002) 587-595
41. Williams C.P., Child D.F., Hudson P.R., De Soysa L., Davies G.K., and De Bolla A.R. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment?. J. Clin. Pathol. 49 (1996) 881-888